viernes, 30 de mayo de 2025
GLP-1s: 3 Lesser-Known Downsides ++++++... American Association of Clinical Endocrinology (AACE) Annual Meeting 2025 May 15 - 17, 2025 | Orlando, Florida
Be Aware of Lesser-Known Downsides to GLP-1 Weight Loss
Miriam E. Tucker
May 22, 2025
https://www.medscape.com/viewarticle/be-aware-lesser-known-downsides-glp-1-weight-loss-2025a1000cwy?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
Sotagliflozin Lowers A1c, Weight Even in Kidney Impairment
Miriam E. Tucker
May 17, 2025
https://www.medscape.com/viewarticle/sotagliflozin-lowers-a1c-weight-even-kidney-impairment-2025a1000ch7?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
Fracture Risk Lower With Semaglutide vs Sleeve Gastrectomy
Miriam E. Tucker
May 16, 2025
https://www.medscape.com/viewarticle/fracture-risk-lower-semaglutide-vs-sleeve-2025a1000cf5?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
Can Endocrine NP Training Help Ease Provider Shortage?
Miriam E. Tucker
May 27, 2025
https://www.medscape.com/viewarticle/can-endocrine-np-training-help-ease-provider-shortage-2025a1000d9w?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
New Data Back Crinecerfont in Congenital Adrenal Hyperplasia
Miriam E. Tucker
May 15, 2025
https://www.medscape.com/viewarticle/new-data-back-crinecerfont-congenital-adrenal-hyperplasia-2025a1000cc7?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
Palopegteriparatide Benefits Sustained in Hypoparathyroidism
Miriam E. Tucker
May 21, 2025
https://www.medscape.com/viewarticle/palopegteriparatide-benefits-sustained-hypoparathyroidism-2025a1000csw?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
American Association of Clinical Endocrinology (AACE) Annual Meeting 2025
https://www.medscape.com/viewcollection/37797?ecd=WNL_conf_endo_AACE-SPON_250529_MSCPEDIT_etid7455849&uac=148436CN&impID=7455849
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario